HON vs ISPC · P/E 36, rev $9.72B vs rev $9.3M
Honeywell International Inc (HON) versus iSpecimen Inc (ISPC) — a side-by-side from cached financials, not a winner call.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal Kapur.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
HON currently screens at market cap $144.86B and trailing P/E 36.5. ISPC currently screens at market cap $4.4M.
Not investment advice. Open the HON and ISPC stock pages for the full models.
Not investment advice.